CAS 216758-20-2

3,4,5-PIPERIDINETRIOL, 2-(HYDROXYMETHYL)-1-[5-(TRICYCLO[3.3.1.13,7]DEC-1-YLMETHOXY)PENTYL]-, (2R,3R,4R,5S)-

CAS : 216758-20-2

Formule : C₂₂H₃₉NO₅

Degré de pureté : 98%

Masse moléculaire : 397.5488

Ref: IN-DA007PGP

AMP-Deoxynojirimycin

CAS : 216758-20-2

AMP-Deoxynojirimycin

Degré de pureté : ≥98%

Masse moléculaire : 397.55g/mol

Ref: 54-BUP00465

AMP-Deoxynojirimycin - Solution in ethanol

CAS : 216758-20-2

Potent inhibitor of non-lysosomal glucosylceramidase, without having any effect on glucosylceramide synthase and glucosidases. Anti-inflammatory and immunosuppressive effect of AMP-DNM demonstrated in a model of hapten-induced colitis in vivo. Reduces glycosphingolipids and increases insulin sensitivity in murine models of obesity-related insulin resistance. Induces sterol regulatory element-binding protein (SREBP) target genes in HepG2 cells, activating cholesterol biosynthesis.

Formule : C₂₂H₃₉NO₅

Degré de pureté : Min. 95%

Couleur et forme : Colorless Clear Liquid

Masse moléculaire : 397.55 g/mol

Ref: 3D-MA31098

AMP-Deoxynojirimycin

CAS : 216758-20-2

AMP-Deoxynojirimycin (AMP-DNM) is a ceramide glucosyltransferase and GCase 2 inhibitor for the study of Parkinson's and diabetes.

Formule : C₂₂H₃₉NO₅

Degré de pureté : >99.99%

Couleur et forme : Solid

Masse moléculaire : 397.55

Ref: TM-T35626